首页 | 本学科首页   官方微博 | 高级检索  
检索        

血清肿瘤标志物研发及临床应用评价新进展
摘    要:恶性肿瘤发生率及病死率居高不下,其根本原因是对恶性肿瘤缺乏早期发现及早期诊断。纵观恶性肿瘤的各种诊断方法,血清检测最为简便、快捷、经济实用,但是目前应用的各种血清标志物的诊断价值尚不能满足临床需求,且运用上尚存在许多不足。因此,如何研发出新的具有较好诊断价值的血清肿瘤标志物具有巨大的市场潜力,对其临床应用进行系统性评价具有重要的意义,将有助于提高我国恶性肿瘤患者的生存率和生活质量。

关 键 词:恶性肿瘤  血清肿瘤标志物  临床应用  评价

Recent Progress of Research and Clinical Application Evaluation of Serum Tumor Markers
Abstract:The root cause of the high incidence and mortality of malignant tumors is the lack of earlier detection and diagnostic methods.Throughout various diagnostic methods,serum detection is the most convenient,efficient and economical,but the diagnostic value of serum markers in application has not met the clinical demands,and the application still needs to be improved.Therefore,how to develop new serum tumor markers with high diagnostic value is imperative,and the systematic evaluation of the clinical application is of great importance,which will help improve the survival rate and life quality of patients with malignant tumors.
Keywords:Malignant tumor  Serum tumor markers  Clinical application  Evaluation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号